Ultrafast CT developer Imatron of South San Francisco, CA, saidthat it plans to open HeartScan imaging centers in Europe in cooperationwith major medical centers. Imatron launched the HeartScan program in the U.S. in 1994to provide coronary artery
Ultrafast CT developer Imatron of South San Francisco, CA, saidthat it plans to open HeartScan imaging centers in Europe in cooperationwith major medical centers.
Imatron launched the HeartScan program in the U.S. in 1994to provide coronary artery disease scanning using Imatron's UltrafastCT scanners. Imatron often markets the services of the clinicsdirectly to the public.
Imatron will adopt a similar strategy in Europe. The companyis in discussions with medical centers in Monte Carlo and Switzerlandas well as in Germany, where a syndicate is interested in openingthree HeartScan centers.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.